Ohno, Kinji

Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease

Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 523

Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease

Nishiwaki, H., Ito, M., Ishida, T., Hamaguchi, T., Maeda, T., Kashihara, K., Tsuboi, Y., Ueyama, J., Shimamura, T., Mori, H., et al. (2020) · Movement Disorders

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 370

Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study

Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M. (2017) · PLOS ONE

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 248

Parkinson’s Disease and Gut Microbiota

Hirayama, M., & Ohno, K. (2021) · Annals of Nutrition and Metabolism

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 158

Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder

Nishiwaki, H., Hamaguchi, T., Ito, M., Ishida, T., Maeda, T., Kashihara, K., Tsuboi, Y., Ueyama, J., Shimamura, T., Mori, H., et al. (2020) · mSystems

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 133

Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease

Nishiwaki, H., Ito, M., Hamaguchi, T., Maeda, T., Kashihara, K., Tsuboi, Y., Ueyama, J., Yoshida, T., Hanada, H., Takeuchi, I., et al. (2022) · npj Parkinson's Disease

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 116

Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia

Selcen, D., Ohkawara, B., Shen, X.-M., McEvoy, K., Ohno, K., & Engel, A. G. (2015) · JAMA Neurology

Myasthenia Gravis and ThymomaMuscle Physiology and Disorders

Cited by 53

Noninvasive monitoring of plasma l-dopa concentrations using sweat samples in Parkinson's disease

Tsunoda, M., Hirayama, M., Tsuda, T., & Ohno, K. (2015) · Clinica Chimica Acta

Parkinson's Disease Mechanisms and TreatmentsElectrochemical sensors and biosensors

Cited by 49

FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD

Fujioka, Y., Ishigaki, S., Masuda, A., Iguchi, Y., Udagawa, T., Watanabe, H., Katsuno, M., Ohno, K., & Sobue, G. (2013) · Scientific Reports

Amyotrophic Lateral Sclerosis ResearchRNA Research and Splicing

Cited by 46

Altered Gut Microbiota in Parkinson’s Disease Patients with Motor Complications

Takahashi, K., Nishiwaki, H., Ito, M., Iwaoka, K., Takahashi, K., Suzuki, Y., Taguchi, K., Yamahara, K., Tsuboi, Y., Kashihara, K., et al. (2022) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 29

Interruption of supramammillohippocampal afferents prevents the genesis and spread of limbic seizures in the hippocampus via a disinhibition mechanism

Saji, M., Kobayashi, S., Ohno, K., & Sekino, Y. (2000) · Neuroscience

Epilepsy research and treatmentMemory and Neural Mechanisms

Cited by 20